12-Month Lobbying Summary - Consultant Lobbyist

Boehringer Ingelheim (Canada) Ltd. / Michael Bailey, Consultant Lobbyist

Registration Summary

Currently active - Last Updated: 2024-09-09 - Projected End Date: 2025-01-31

Who is lobbying?

Boehringer Ingelheim (Canada) Ltd. (Address & business activities)

Government Funding

Did Boehringer Ingelheim (Canada) Ltd. request or receive government funding within the last 12 months? No

Coalition Members Information

Boehringer Ingelheim (Canada) Ltd. is not a coalition member.

Direct Interests of the Lobbying Activity

Affiliates

Boehringer Ingelheim (Canada) Ltd. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

Boehringer Ingelheim International GmbH (Address information)

Other Affiliates

The activities of Boehringer Ingelheim (Canada) Ltd. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of Boehringer Ingelheim (Canada) Ltd.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will the consultant lobbyist be arranging meetings between a public office holder and the client for the purpose of attempting to influence any of the matters listed:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Advocated for the development of a public/private partnership with government regarding a program to provide a virtual health initiative around heart failure.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Arranged a Zoom meeting with Mr. Bob D'Eith, representatives of Boehringer Ingelheim, and me.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Arranged a Zoom meeting with Mr. Jagrup Brar, representatives of Boehringer Ingelheim, and me.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Arranged a Zoom meeting with Ms. Rachna Singh, representatives of Boehringer Ingelheim, and me.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Cancelled a request for a Teams meeting so that Min. Kahlon, DM Bobbi Plecas and Parliamentary Secretary Ms. Brenda Bailey can meet with Ms. Andrea Sambati, CEO, Boehringer Ingelheim to discuss possible partnerships.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Contacted Ms. Alysa Huppler-Poliak to request that a Zoom meeting be arranged with Mr. Bob D'Eith, representatives of Boehringer Ingelheim, and me.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Contacted Ms. Kiran Sidhu to Arrange a Zoom meeting with Mr. Ravi Kahlon	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Contacted Ms. Sarina Grewal to confirm a Zoom meeting between Ms. Rachna Singh, representatives of Boehringer Ingelheim, and me.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Contacted Ms. Sarina Grewal to request that a Zoom meeting be arranged with Ms. Rachna Singh, representatives of Boehringer Ingelheim, and me.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Discussed BI's desire to partner with Government with Mr. Ravi Hahlon	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Discussed BI's desire to partner with Government with Ms. Rachna Singh.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Discusses BI's desire to partner with Government with Mr. Bob D'Eith.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Discussions with officials concerning the development of a partnership with government regarding a program to provide virtual health services for chronic disease care.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Emailed a request for a Teams meeting so that Min. Rankin and DM Doug Caul may meet with Ms. Andrea Sambati, CEO, Boehringer Ingelheim to discuss possible partnerships.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Emailed a request for a Teams meeting so that Mr. Meggs may meet with Ms. Andrea Sambati, CEO, Boehringer Ingelheim to discuss possible partnerships.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Had a discussion around how BC PharmaCare will possibly interact with the proposed National PharmaCare program	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Had a phone call and requested information regarding priority areas of reimbursement for rare disease drugs.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Had Zoom meeting with Mr. Garry Begg, representatives pf Boehringer Ingelheim, and me to discuss a possible partnership with government around virtual healthcare	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Had Zoom meeting with Mr. Jagrup Brar, representatives pf Boehringer Ingelheim, and me to discuss a possible partnership with government around virtual healthcare	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Provided a Brief on existing partnerships and projects between Boehringer Ingelheim and the Government of BC, and to advocate for the development of future partnerships and projects.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Requested a Zoom meeting between Mr. Nicholas Simons, representatives of Boehringer Ingelheim, and me.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Requested Mr. Begg to organize a Zoom meeting of the Surrey NDP Caucus	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Sent email requesting proper procedure to request a meeting with MLA Jennifer Rice in her role as Parliamentary Secretary for Rural Health. Emailed a Briefing Note on existing partnerships and projects between Boehringer Ingelheim and the Government of BC, and to advocate for the development of future partnerships and projects.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Spoke to and emailed a request for a Teams meeting so that Ms. Isobel Mackenzie may meet with Ms. Andrea Sambati, CEO, Boehringer Ingelheim to discuss possible partnerships.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Spoke to and emailed a request to meet with Jeremy Hewitt and Kevin Jardine, as well as with Aman Singh. Emailed a Briefing Note on existing partnerships and projects between Boehringer Ingelheim and the Government of BC, and to advocate for the development of future partnerships and projects.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Spoke to and emailed request to meet with DM Tom McCarthy and ADM Jennifer Melles. Emailed a Briefing Note on existing partnerships and projects between Boehringer Ingelheim and the Government of BC, and to advocate for the development of future partnerships and projects.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Spoke to Ms. Amna Shah to arrange a conference call between Mr. Garry Begg, representatives from Boehringer Ingelheim, and me.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Spoke to Ms. Amna Shah to arrange a conference call between Mr. Garry Begg, representatives from Boehringer Ingelheim, and me.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
Spoke with Ms. Alysa Huppler-Poliak to confirm a Zoom meeting with Mr. Bob D'Eith, representatives of Boehringer Ingelheim, and me.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health, Information Technology
To advocate for policy development with a focus on health care and public drug program funding	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health

Gifts or Benefits Provided to Public Officer Holders

Lobbyists are required to provide information regarding gifts or benefits provided within the last 12 months to a public office holder they have lobbied. For more information, review the Guide to Lobbyist Gifts.

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Environment and Climate Change Strategy
Fraser Health Authority
Health
Indigenous Relations and Reconciliation
Jobs, Economic Development and Innovation
Member(s) of the BC Legislative Assembly
Parliamentary Secretary for Community Development and Non-Profits

Who is the lobbyist?

Michael Bailey, Consultant Lobbyist (Business address and contact information)

Western Policy Consultants Inc. (Address & contact information)

Former Public Office Holder in BC: Yes

Relevant Codes of Conduct: The consultant lobbyist does not have in place an undertaking to comply with any relevant codes of conduct.

Individuals Hired by the Consultant Lobbyist to Lobby on Behalf of the Client:

Karin MacMillan

Individuals hired in previous versions
Registration version: 3
- Karin MacMillan

Contingency Information:

Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the outcome of this lobbying activity.
Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the success in arranging a meeting with public office holders on behalf of the client.

Who has provided contributions?

Consultant has lobbied a member of the Legislative Assembly, including a Minister or Premier, on behalf of this client, any time on or after 2020-09-21 and before 2024-09-21:

Yes

Has made a political contribution as defined in the Lobbyists Transparency Act on or after 2020-09-21 and before 2024-09-21:	Consultant:	No
	Client:	No
Has made a sponsorship contribution as defined in the Lobbyists Transparency Act on or after 2020-09-21 and before 2024-09-21:	Consultant:	No
	Client:	No
Has made a recall contribution as defined in the Lobbyists Transparency Act on or after 2020-09-21 and before 2024-09-21:	Consultant:	No
	Client:	No

Consultant has lobbied, or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this client, on or after 2024-09-21:

Yes

Has made a political contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No
Has made a sponsorship contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No
Has made a recall contribution as defined in the Lobbyists Transparency Act on or after 2024-09-21:	Consultant:	No
	Client:	No

Registration number: 1054-332
View all registrations versions

Lobbying Activity Reports

What lobbying activities have taken place in the last 12 months?

What lobbying activities have taken place in the last 12 months?
Date	Arranging a Meeting	Senior Public Office Holder, Position Title \| Ministry/Provincial Entity	Subject Matters
2024-09-09	Yes	Christianne Taylor, Executive Assistant to the Board of Directors \| Fraser Health Authority	View
2024-08-13	Yes	Dillan Halter, Executive Director \| Health Raj Maharaj, Director, Indigenous Health and Reconciliation Division \| Health Jennifer Sheppard, Acting Manager \| Executive Operations, Health	View
2024-07-03	Yes	Elaine Cross, Executive Director \| Innovation Programs & Partnership, Environment and Climate Change Strategy Chris Koski, Director, Clean Government \| Environment and Climate Change Strategy Aman Singh, MLA for Richmond-Queensborough \| Member(s) of the BC Legislative Assembly Mary Ward, Executive Assistant \| Minister's Office, Environment and Climate Change Strategy	View
2024-06-10	Yes	Josh McLeod, Constituency Assistant to ADM Jennifer Rice and Parliamentary Secretary for Rural Health \| Health Cyndee Numberger, Executive Assistant to Jeremy Hewitt \| Environment and Climate Change Strategy Aman Singh, MLA for Richmond-Queensborough \| Member(s) of the BC Legislative Assembly	View
2024-06-07	Yes	Josie Midiaga, Executive Administrative Assistant to Jennifer Melles, ADM, Strategic Partnerships and Initiatives Division \| Indigenous Relations and Reconciliation	View
2024-06-05	Yes	Hasham Kamran, Senior Advisor to Honourable Sheila Malcolmson \| Minister of Social Development and Poverty Reduction, Parliamentary Secretary for Community Development and Non-Profits Scott McKenzie, Acting Communications Director \| Jobs, Economic Development and Innovation Jack Shewchuk, Director of Communications \| Health	View
2024-05-27	Yes	Jen Sheppard, Manager, Executive Operations \| Health	View
2024-03-12	Yes	Tijana Fazlagic, Executive Director \| Therapeutic Assessment &Access Branch, Health	View

View all Lobbying Activity Reports

Boehringer Ingelheim (Canada) Ltd. - Address & business activities

Address:

5180 South Service Road
Burlington, ON L7L 5H4
Canada

Telephone number: 778-908-8847

Website: www.boehringer-ingelheim.com

Contact information in previous versions
- 5180 South Service Road
  Burlington, ON L7L 5H4
  Canada
  
  Telephone number: 604-604-6443
  
  Website: www.boehringer-ingelheim.com
- 5180 South Service Road
  
  Burlington, ON L7L 5H4
  Canada
  
  Telephone number: 604-604-6443
- 5180 South Service Road
  
  Burlington, ON L7L 5H4
  Canada
  
  Telephone number: 905-639-0333
- 5180 SOUTH SERVICE ROAD
  
  BURLINGTON, ON L7L 5H4
  Canada
  
  Telephone number: 604-275-0859
  
  Fax number: 604-275-0859

Description of Activities:
Boehringer Ingelheim is a research-driven company dedicated to the discovery, development, manufacture and marketing of innovative health care products.

Descriptions of the organization's activity in previous versions:
- Since our arrival in Canada in 1972 we have played a varied and integral role in the health of Canadians. We are committed to finding medical breakthroughs and investing in research, development and medicine for therapies which fulfill unmet medical needs. Through our participation in medical and pharmaceutical research, both in Canada and worldwide, we have contributed to significant improvements in healthcare and developed innovative and cost-effective medicines. We have earned a reputation as a leader in the treatment of respiratory diseases, in particular Chronic Obstructive Pulmonary Disease (COPD), and have broadened the scope of our work to include diseases such as hypertension, stroke, arthritis, benign prostatic hyperplasia (BPH), Parkinson's disease and HIV/AIDS.
- Committed to finding medical breakthroughs and investing in research, development and medicine for therapies which fulfill unmet medical needs. Through their participation in medical and pharmaceutical research, both in Canada and worldwide, they have contributed to significant improvements in healthcare and developed innovative and cost-effective medicines. They have earned a reputation as a leader in the treatment of respiratory diseases, in particular Chronic Obstructive Pulmonary Disease (COPD), and have broadened the scope of their work to include diseases such as hypertension, stroke, arthritis, benign prostatic hyperplasia (BPH), Parkinson's disease and HIV/AIDS.
- PHARMACEUTICAL FIRM

Date Modified:: 2024-10-03

Menus

www.lobbyistsregistrar.bc.ca

12-Month Lobbying Summary - Consultant Lobbyist

Boehringer Ingelheim (Canada) Ltd. / Michael Bailey, Consultant Lobbyist

Who is lobbying?

Boehringer Ingelheim (Canada) Ltd. (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

What is being lobbied?

Details Regarding the Identified Subject Matter

Gifts or Benefits Provided to Public Officer Holders

Who is being lobbied?

Ministries/Provincial Entities

Who is the lobbyist?

Michael Bailey, Consultant Lobbyist (Business address and contact information)

Who has provided contributions?

What lobbying activities have taken place in the last 12 months?

12-Month Lobbying Summary - Consultant Lobbyist

Boehringer Ingelheim (Canada) Ltd. / Michael Bailey, Consultant Lobbyist

Boehringer Ingelheim (Canada) Ltd. (Address & business activities)

Government Funding

Coalition Members Information

Direct Interests of the Lobbying Activity

Affiliates

Other Affiliates

Contributors with a Direct Interest in the Outcome

Details Regarding the Identified Subject Matter

Gifts or Benefits Provided to Public Officer Holders

Ministries/Provincial Entities

Michael Bailey, Consultant Lobbyist (Business address and contact information)

Boehringer Ingelheim (Canada) Ltd. - Address & business activities

Boehringer Ingelheim (Canada) Ltd. / Michael Bailey, Consultant Lobbyist

Western Policy Consultants Inc.

Boehringer Ingelheim International GmbH